MedTrace Logo

Reduction of Intrapartum Fever With Intravenous Acetaminophen

NCT02625454 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2019-07-17

No results posted yet for this study

Summary

The investigators plan to administer acetaminophen (Tylenol) for the treatment of fever in laboring patients by either an oral or intravenous (IV) route. The investigators want to see if the maternal fever will decrease faster with the IV or the oral dose. The investigators also want to look at other outcomes such as the cesarean section rate, the rate of neonatal intensive care unit admissions in both groups.

Conditions

Interventions

DRUG

Intravenous Acetaminophen

1000 mg Acetaminophen q 6 hours, given intravenously

DRUG

Oral Acetaminophen

1000 mg Acetaminophen q 6 hours given orally

Sponsors & Collaborators

  • Richmond University Medical Center

    lead OTHER

Principal Investigators

  • Nisha Lakhi, MD · Richmond University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-05-31
Completion
2019-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02625454 on ClinicalTrials.gov